That, he says, is exactly what would be needed for the drug to be approved by the Food and Drug Administration as a disease-modifying agent, not just a treatment of symptoms.
FORBES: Magazine Article
2.
Forty-one per cent of those who said they did have enough information about drug treatments still did not take a disease-modifying treatment.
BBC: Multiple sclerosis patients are missing out on drugs